Current VIP study: the COVIP study 2022 extension
Corona Virus disease (COVID19) in Very Elderly Intensive care Patients (VIPs).
The COVIP-study is a multinational, prospective, observational study running from 2020 and into 2022.
Close to 4000 patients were recruited in 2020-2021 and the COVIP study is now starting a second recruitment period (the 2022-extension).
Please see the COVIP page for information.
COVIP 2022 extension status:
122 ICUs registered
(Updated: 20-05-2022 00:18)13 countries participating
(Updated: 20-05-2022 00:18)153 patients documented
(Updated: 20-05-2022 00:18)COVIP 2020-2021 status:
376 ICUs registered
(Updated: 24-02-2022 01:14)44 countries participating
(Updated: 24-02-2022 01:14)3978 patients documented
(Updated: 24-02-2022 01:14)
Recent VIP publications
2022-04-29: Fronczek J et al. Short-term mortality of patients ≥80 years old admitted to European intensive care units: an international observational study. Br J Anaesth.2022-04-05: Wernly B et al. Variations in end-of-life care practices in older critically ill patients with COVID-19 in Europe. J Intern Med.
2022-03-19: Bruno RR et al. Association of chronic heart failure with mortality in old intensive care patients suffering from Covid-19. ESC Heart Fail.
2022-03-18: Bruno RR et al. The association of the Activities of Daily Living and the outcome of old intensive care patients suffering from COVID-19. Ann Intensive Care.
2022-02-26: Guidet B et al. Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19. Intensive Care Med.
See the VIP-papers page for a list of studies from the VIP-network.